Your browser doesn't support javascript.
loading
Trends in treatment and survival for advanced laryngeal cancer: A 20-year population-based study in The Netherlands.
Timmermans, Adriana J; van Dijk, Boukje A C; Overbeek, Lucy I H; van Velthuysen, Marie-Louise F; van Tinteren, Harm; Hilgers, Frans J M; van den Brekel, Michiel W M.
Afiliación
  • Timmermans AJ; Department of Head and Neck Oncology and Surgery, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • van Dijk BA; Netherlands Comprehensive Cancer Organisation (IKNL), Department of Research, Utrecht, The Netherlands.
  • Overbeek LI; University of Groningen, University Medical Centre Groningen, Department of Epidemiology, Groningen, The Netherlands.
  • van Velthuysen ML; PALGA (the Dutch nationwide network and registry of histopathology and cytopathology), Houten, The Netherlands.
  • van Tinteren H; PALGA (the Dutch nationwide network and registry of histopathology and cytopathology), Houten, The Netherlands.
  • Hilgers FJ; Department of Pathology, the Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • van den Brekel MW; Biometrics Department, the Netherlands Cancer Institute, Amsterdam, The Netherlands.
Head Neck ; 38 Suppl 1: E1247-55, 2016 04.
Article en En | MEDLINE | ID: mdl-26315454
BACKGROUND: The purpose of this study was to determine time trends for primary treatment modalities in advanced laryngeal cancer, overall survival (OS), and laryngectomy-free interval (LFI) over the last 2 decades in The Netherlands. METHODS: We conducted an analysis of T3 to T4 laryngeal cancer data from 2 combined national (population-based and pathology-based) cancer registries. RESULTS: A total of 2072 T3 cases (14.7%) and 1722 T4 cases (12.2%) were identified. Total laryngectomy as primary treatment modality decreased, whereas radiotherapy (RT) increased. For T3 disease, 5-year OS after primary total laryngectomy (+/- adjuvant RT), RT, and chemoradiotherapy (CRT) was 49%, 47%, and 45%, respectively. For T4 disease, this was 48%, 34%, and 42% (overall p < .0001), respectively. Five-year LFI for T3 disease was 81% (RT) and 77% (CRT), and for T4 disease it was 81% and 87%, respectively. CONCLUSION: From 1991 to 2010 total laryngectomy as primary treatment modality for advanced laryngeal cancer decreased and RT increased. T3 disease showed similar survival rates for all primary treatment modalities. For T4 disease, total laryngectomy (+ adjuvant RT) showed the best survival. © 2015 Wiley Periodicals, Inc. Head Neck 38: E1247-E1255, 2016.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Laríngeas Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Head Neck Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Laríngeas Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Head Neck Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos